QT
MRVI icon

Quantbot Technologies’s Maravai LifeSciences MRVI Stock Holding History

Quantbot Technologies’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Buy
42,955
+41,519
+2,891% +$179K 0.01% 1164
2026
Q1 		$4.06K Sell
1,436
-58,887
-98% -$200K ﹤0.01% 1585
2025
Q4 		$196K Buy
60,323
+29,449
+95% +$99.1K 0.01% 1243
2025
Q3 		$88.6K Buy
+30,874
New +$78.8K ﹤0.01% 1449
2024
Q4 		– Sell
-7,432
Closed -$61.8K – 1694
2024
Q3 		$61.8K Sell
7,432
-8,945
-55% -$77.3K ﹤0.01% 1254
2024
Q2 		$117K Buy
+16,377
New +$141K 0.01% 1094
2023
Q4 		– Sell
-65,219
Closed -$652K – 1841
2023
Q3 		$652K Buy
+65,219
New +$716K 0.04% 550
2023
Q1 		– Sell
-127,030
Closed -$1.82M – 1872
2022
Q4 		$1.82M Buy
+127,030
New +$2M 0.13% 237
2022
Q2 		– Sell
-69,305
Closed -$2.44M – 1968
2022
Q1 		$2.44M Buy
69,305
+43,444
+168% +$1.46M 0.21% 118
2021
Q4 		$1.08M Buy
25,861
+10,337
+67% +$419K 0.09% 332
2021
Q3 		$761K Sell
15,524
-53,136
-77% -$2.59M 0.06% 468
2021
Q2 		$2.87M Buy
68,660
+61,629
+877% +$2.39M 0.23% 116
2021
Q1 		$250K Buy
+7,031
New +$233K 0.02% 664

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Quantbot Technologies's MRVI Position: Q2 2026 in Review

Quantbot Technologies increased its Maravai LifeSciences (MRVI) stake by 2,891% in Q2 2026, buying an estimated $179K and bringing the position to 42,955 shares worth $268K. The position accounts for 0.01% of the portfolio, ranked #1164.

Quantbot Technologies first reported a position in MRVI in Q1 2021 and has held it in 13 quarters since. The position peaked at $2.87M in Q2 2021. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Quantbot Technologies held 42,955 shares of Maravai LifeSciences worth $268K as of Q2 2026.
  • Quantbot Technologies bought 41,519 Maravai LifeSciences shares in Q2 2026, an estimated $179K.
  • Maravai LifeSciences made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1164 holding.
  • Quantbot Technologies first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 13 quarters since.
  • Quantbot Technologies's Maravai LifeSciences position peaked at $2.87M in Q2 2021.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.